Device Orthopedics

Csr & R1 Reverse Total Shoulder Systems

Payments companies reported to CMS as associated with Csr & R1 Reverse Total Shoulder Systems. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$39Kassociated payments (2023-2025)
89clinicians with associated payments
1company reporting

By year

2023 $39K

Payments reported as associated with Csr & R1 Reverse Total Shoulder Systems, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $30K
Sports Medicine (Orthopaedic Surgery) $6,454
Adult Reconstructive Orthopaedic Surgery $1,331
Physician Assistant $854
Hand Surgery $375
Orthopaedic Surgery of The Spine $168

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Csr & R1 Reverse Total Shoulder Systems

These are the largest totals companies reported as associated with Csr & R1 Reverse Total Shoulder Systems. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Miguel Ramirez Peoria, IL Orthopaedic Surgery $2,867.01
Steven Goldberg Naples, FL Orthopaedic Surgery $1,762.27
Ira Parsons Somersworth, NH Orthopaedic Surgery $1,513.49
Travis Burns San Antonio, TX Orthopaedic Surgery $1,329.13
Zachary Leitze St George, UT Orthopaedic Surgery $1,174.27
Aaron Bare Warrenville, IL Orthopaedic Surgery $1,154.27
John Brown Sun City West, AZ Sports Medicine (Orthopaedic Surgery) $1,154.27
Sean Bak Dearborn, MI Orthopaedic Surgery $1,112.95
Michael Messina Aurora, CO Orthopaedic Surgery $1,032.25
Brian Galinat Wilmington, DE Orthopaedic Surgery $1,032.25

Prescribed Csr & R1 Reverse Total Shoulder Systems?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.